STOCK TITAN

Nurix Therapeutics officer plans $130K share sale

Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Nurix Therapeutics, Inc. officer Christine Ring reported a planned sale of 8,148 common shares, with an aggregate market value of $130,123.56 and an approximate sale date of March 2, 2026. Morgan Stanley Smith Barney LLC is listed as broker. The shares were acquired upon vesting of restricted stock units between May 2, 2022 and January 30, 2025. The notice gives November 10, 2025 as the Rule 10b5-1 plan adoption or instruction date. It also lists four prior 10b5-1 sales: 8,148 shares for gross proceeds of $135,757.90 and 6,113 shares for $101,860.92 on February 9, 2026; 3,760 shares for $69,273.11 on January 20, 2026; and 3,760 shares for $67,314.15 on December 18, 2025.

Shares to be sold 8,148 shares Approximate sale date: March 2, 2026
Aggregate market value $130,123.56 Shares proposed for sale
Shares outstanding 102,843,012 shares Securities information section
Prior sale, February 9, 2026 8,148 shares; $135,757.90 gross proceeds Common stock
Prior sale, February 9, 2026 6,113 shares; $101,860.92 gross proceeds Common stock
Prior sale, January 20, 2026 3,760 shares; $69,273.11 gross proceeds Common stock
Prior sale, December 18, 2025 3,760 shares; $67,314.15 gross proceeds Common stock
Restricted Stock Units financial
"Nature of Acquisition Transaction: Restricted Stock Units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Rule 10b5-1 regulatory
"Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Aggregate Market Value financial
"Number of Shares or Other Units To Be Sold | Aggregate Market Value"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Gross Proceeds financial
"Amount of Securities Sold | Gross Proceeds"
The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NRIX shares does Christine Ring plan to sell?

Christine Ring, an officer of Nurix Therapeutics, Inc., reported a planned sale of 8,148 common shares, with an aggregate market value of $130,123.56 and an approximate sale date of March 2, 2026. Morgan Stanley Smith Barney LLC is listed as broker. The notice gives November 10, 2025 as the Rule 10b5-1 plan adoption or instruction date.

What earlier NRIX stock sales did Christine Ring report?

The notice lists four prior sales: 8,148 shares for $135,757.90 and 6,113 shares for $101,860.92 on February 9, 2026; 3,760 shares for $69,273.11 on January 20, 2026; and 3,760 shares for $67,314.15 on December 18, 2025. The amounts are reported as gross proceeds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading